A new United States Pharmacopeia (USP) Chapter 1046: cell and gene therapy products.
The United States Pharmacopeia (USP) has published the first draft of a new information chapter on cell and gene therapy products in January, 2000. The chapter discusses the manufacturing and testing cell and gene therapy products. It is intended for people working in the field as well as for pharmacists and clinicians who would like more information on this subject. This article outlines the background of USP and explains how it became involved with cell and gene therapy and what an information chapter is. It details the subjects covered by the chapter and the philosophy behind the chapter. This draft will be revised based on comments received from the public and then published as a revision subject to further comments before it becomes an official chapter in a supplement to USP 24-NF 19.
Seaver
S
S
Seaver Associates, Concord, MA 01742, USA.
D026683:Advisory Committees / Q000331:legislation & jurisprudence; D064987:Cell- and Tissue-Based Therapy / Q000592:standards*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004501:Education, Medical / Q000592:standards; D015316:Genetic Therapy / Q000331:legislation & jurisprudence* / Q000592:standards*; D011639:Public Opinion; D014481:United States